Ferring Deutschland: Presseaussendungen

Monday, October 24, 2011

Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA^®) in active ulcerative colitis

Thursday, October 20, 2011

Ferring Pharmaceuticals acquires Cytokine PharmaSciences Inc.

Friday, September 02, 2011

New research reveals night-time toilet trips are not a trivial problem

Friday, September 02, 2011

New research reveals night-time toilet trips are not a trivial problem

|Read Press Release|

Friday, September 02, 2011

The untold impact of childhood bedwetting in later life

|Read Press Release|

Wednesday, August 31, 2011

New data demonstrating long-term benefits of FIRMAGON^® (degarelix) for advanced hormone-dependant prostate cancer published in The Journal of Urology

|Read Press Release|

Wednesday, July 06, 2011

MEGASET Study demonstrated effectiveness and tolerability of MENOPUR^® after ICSI in GnRH antagonist cycles

|Read Press Release|

Monday, March 21, 2011

Ongoing extension study results provide further evidence for first-line use of FIRMAGON^® (degarelix) in advanced prostate cancer

|Read Press Release|